STING1 and neoplasm: As shown in Fig. 4A, we employed a prophylactic protocol setting in which two cycles of either PBS, STING-LNPs, CpG-ODNs, or the combination therapy were intravenously administered on days 0 and 4, followed by tumor inoculation on day 5.